›› 2009, Vol. 27 ›› Issue (6): 13-519.

• 综述 • Previous Articles     Next Articles

Research Progress on the Efficacy, Metabolism and Bioavailability of Mebendazole in Hydatid Disease

LIU Cong-shan,ZHANG Hao-bing*   

  1. National Institute of Parasitic Diseases,Chinese Center for Disease Control and Prevention,Key Laboratory of Parasite and Vector Biology,MOH,WHO Collaborating Centre for Malaria, Schistosomiasis and Filariasis,Shanghai 200025,China
  • Received:1900-01-01 Revised:1900-01-01 Online:2009-12-30 Published:2009-12-30

Abstract: Mebendazole is currently used in the treatment of hydatid disease. Its poor absorption from the gastrointestinal tract and low bioavailability aroused further research on new formulations of mebendazole to increase the bioavailability and improve the therapeutic efficacy. This review summarizes the recent research progress.

Key words: Mebendazole, Pharmacokinetics, Bioavailability, Echinococcus granulosus, Echinococcus multilocularis, Hydatid disease